Back to Search
Start Over
GloPID-R report on Chikungunya, O'nyong-nyong and Mayaro virus, part I: Biological diagnostics
- Source :
- Antiviral Research, Antiviral Research, 2019, 166, pp.66-81. ⟨10.1016/j.antiviral.2019.03.009⟩, Antiviral Research, Elsevier Masson, 2019, 166, pp.66-81. ⟨10.1016/j.antiviral.2019.03.009⟩, ANTIVIRAL RESEARCH, Antiviral Research, 166, 66-81. Elsevier
- Publication Year :
- 2019
- Publisher :
- HAL CCSD, 2019.
-
Abstract
- The GloPID-R (Global Research Collaboration for Infectious Disease Preparedness) Chikungunya (CHIKV), O'nyong-nyong (ONNV) and Mayaro virus (MAYV) Working Group is investigating the natural history, epidemiology and medical management of infection by these viruses, to identify knowledge gaps and to propose recommendations for direct future investigations and rectification measures. Here, we present the first report dedicated to diagnostic aspects of CHIKV, ONNV and MAYV. Regarding diagnosis of the disease at the acute phase, molecular assays previously described for the three viruses require further evaluation, standardized protocols and the availability of international standards representing the genetic diversity of the viruses. Detection of specific IgM would benefit from further investigations to clarify the extent of cross-reactivity among the three viruses, the sensitivity of the assays, and the possible interfering role of cryoglobulinaemia. Implementation of reference panels and external quality assessments for both molecular and serological assays is necessary. Regarding sero-epidemiological studies, there is no reported high-throughput assay that can distinguish among these different viruses in areas of potential co-circulation. New specific tools and/or improved standardized protocols are needed to enable large-scale epidemiological studies of public health relevance to be performed. Considering the high risk of future CHIKV, MAYV and ONNV outbreaks, the Working Group recommends that a major investigation should be initiated to fill the existing diagnostic gaps. ispartof: ANTIVIRAL RESEARCH vol:166 pages:66-81 ispartof: location:Netherlands status: published
- Subjects :
- 0301 basic medicine
medicine.medical_specialty
Genes, Viral
030106 microbiology
Disease
Alphavirus
Mosquito Vectors
Cross Reactions
medicine.disease_cause
Antibodies, Viral
Communicable Diseases, Emerging
Virus
03 medical and health sciences
Seroepidemiologic Studies
Virology
O'nyong-nyong
Epidemiology
medicine
Animals
Humans
O'nyong-nyong Virus
Chikungunya
Pathology, Molecular
Diagnostics
Phylogeny
Pharmacology
biology
business.industry
Alphavirus Infections
Outbreak
biology.organism_classification
Mayaro virus
3. Good health
030104 developmental biology
Cryoglobulinemia
Infectious disease (medical specialty)
Preparedness
[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology
Chikungunya Fever
business
Chikungunya virus
Subjects
Details
- Language :
- English
- ISSN :
- 01663542
- Database :
- OpenAIRE
- Journal :
- Antiviral Research, Antiviral Research, 2019, 166, pp.66-81. ⟨10.1016/j.antiviral.2019.03.009⟩, Antiviral Research, Elsevier Masson, 2019, 166, pp.66-81. ⟨10.1016/j.antiviral.2019.03.009⟩, ANTIVIRAL RESEARCH, Antiviral Research, 166, 66-81. Elsevier
- Accession number :
- edsair.doi.dedup.....64c66c9fe5a2697fd7854560c63ac589
- Full Text :
- https://doi.org/10.1016/j.antiviral.2019.03.009⟩